Business Description

Description
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Financial Strength

Name Current Vs Industry Vs History
Debt-to-EBITDA 1.21
Interest Coverage 24.5

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % 36.53

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio 0.58
PE Ratio without NRI 0.57
FCF Yield % 4304.29

Financials

FRA:GNJC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Skystar Bio-Pharmaceutical Co Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 36.689
EPS (TTM) (€) 1
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % 0
52-Week Range (€) 0.43 - 3.99
Shares Outstanding (Mil) 8.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Skystar Bio-Pharmaceutical Co Filings

Filing Date Document Date Form
No Filing Data

Skystar Bio-Pharmaceutical Co Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Skystar Bio-Pharmaceutical Co Frequently Asked Questions

What is Skystar Bio-Pharmaceutical Co(FRA:GNJC)'s stock price today?
The current price of FRA:GNJC is €0.58. The 52 week high of FRA:GNJC is €3.99 and 52 week low is €0.43.
When is next earnings date of Skystar Bio-Pharmaceutical Co(FRA:GNJC)?
The next earnings date of Skystar Bio-Pharmaceutical Co(FRA:GNJC) is .
Does Skystar Bio-Pharmaceutical Co(FRA:GNJC) pay dividends? If so, how much?
Skystar Bio-Pharmaceutical Co(FRA:GNJC) does not pay dividend.

Press Release

Subject Date
No Press Release